MOORE TIMOTHY L.
Insider CIK 1669207 · CERS Director · KITE EVP, Technical Operations · ALLO Chief Technical Officer · TIL Chief Operating Officer · BLFS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLFS BIOLIFE SOLUTIONS INC | D To issuer | 2026-10-06 | 2026-10-08 | 44,943 | — | — | 0 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2026-02-24 | 2026-02-26 | 8,170 | — | $0 | 44,943 | SEC↗ |
| CERS CERUS CORP | A Award | 2025-06-03 | 2025-06-04 | 60,000 | — | $0 | 205,073 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2025-03-18 | 2025-03-20 | 6,876 | — | $0 | 36,773 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2025-02-03 | 2025-02-05 | 14,746 | $1.71 | $25.2K | 250,713 | SEC↗ |
| CERS CERUS CORP | A Award | 2024-06-05 | 2024-06-06 | 40,000 | $5.00 | $200.0K | 145,073 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2024-04-22 | 2024-04-24 | 17,360 | $3.47 | $60.2K | 265,459 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2024-03-08 | 2024-03-12 | 11,264 | — | $0 | 29,897 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-01-25 | 2024-01-31 | 341,515 | — | $0 | 341,515 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-01-25 | 2024-01-31 | 96,600 | — | $0 | 282,819 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2023-11-01 | 2023-11-03 | 495 | — | $0 | 18,633 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2023-10-01 | 2023-10-10 | 362 | — | $0 | 18,138 | SEC↗ |
| CERS CERUS CORP | A Award | 2023-06-07 | 2023-06-09 | 40,000 | $5.00 | $200.0K | 105,073 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-04-24 | 2023-04-26 | 831,024 | — | $0 | 831,024 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-04-24 | 2023-04-26 | 186,219 | — | $0 | 186,219 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2023-01-03 | 2023-01-18 | 10,187 | — | $0 | 17,776 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2022-09-06 | 2022-09-06 | 750,000 | — | $0 | 750,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2022-09-01 | 2022-09-06 | 7,589 | — | $0 | 7,589 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2022-06-01 | 2022-06-03 | 39,866 | — | $0 | 39,866 | SEC↗ |
| CERS CERUS CORP | A Award | 2022-06-01 | 2022-06-03 | 20,454 | — | $0 | 65,073 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2021-09-05 | 2021-09-08 | 4,296 | — | $0 | 0 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2021-09-05 | 2021-09-08 | 4,296 | — | $0 | 44,619 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2021-06-02 | 2021-06-03 | 29,983 | — | $0 | 29,983 | SEC↗ |
| CERS CERUS CORP | A Award | 2021-06-02 | 2021-06-03 | 14,888 | — | $0 | 40,323 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2021-06-01 | 2021-06-03 | 13,228 | — | $0 | 0 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2021-06-01 | 2021-06-03 | 13,228 | — | $0 | 25,435 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2020-09-05 | 2020-09-08 | 4,296 | — | $0 | 4,296 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2020-09-05 | 2020-09-08 | 4,296 | — | $0 | 12,207 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2020-06-03 | 2020-06-05 | 28,177 | — | $0 | 28,177 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2020-06-03 | 2020-06-05 | 13,228 | — | $0 | 13,228 | SEC↗ |
| CERS CERUS CORP | P Buy | 2020-02-11 | 2020-02-13 | 3,614 | $4.75 | $17.2K | 7,911 | SEC↗ |
| CERS CERUS CORP | P Buy | 2020-01-29 | 2020-02-03 | 3,614 | $4.15 | $15.0K | 7,911 | SEC↗ |
| CERS CERUS CORP | P Buy | 2020-01-29 | 2020-02-13 | 0 | — | $0 | 4,297 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2019-09-05 | 2019-09-10 | 4,297 | — | $0 | 8,592 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2019-09-05 | 2019-09-10 | 4,297 | — | $0 | 4,297 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2019-06-05 | 2019-06-07 | 23,703 | — | $0 | 23,703 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2019-06-05 | 2019-06-07 | 11,184 | — | $0 | 11,184 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2018-09-05 | 2018-09-07 | 24,324 | — | $0 | 24,324 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2018-09-05 | 2018-09-07 | 12,889 | — | $0 | 12,889 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 96,875 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 124,125 | $135.09 | $16.77M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 30,700 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 3,927 | $180.00 | $706.9K | 41,734 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 41,734 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-09-25 | 2017-09-27 | 8,000 | — | $0 | 49,889 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-09-25 | 2017-09-27 | 4,228 | $179.66 | $759.6K | 45,661 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-08-03 | 2017-08-04 | 6,000 | — | $0 | 146,000 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-08-03 | 2017-08-04 | 6,000 | $44.91 | $269.5K | 55,400 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-03 | 2017-08-04 | 5,131 | $110.05 | $564.7K | 49,400 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-03 | 2017-08-04 | 869 | $110.10 | $95.7K | 54,531 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-08-01 | 2017-08-03 | 3,000 | — | $0 | 152,000 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 321 | $109.35 | $35.1K | 49,400 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-08-01 | 2017-08-03 | 3,000 | $44.91 | $134.7K | 61,400 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 2,477 | $106.85 | $264.7K | 58,923 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 5,431 | $107.58 | $584.3K | 53,492 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 3,771 | $108.27 | $408.3K | 49,721 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-15 | 2017-09-27 | 7,511 | $83.31 | $625.7K | 41,889 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-12-22 | 2016-12-27 | 30,700 | — | $0 | 30,700 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-12-22 | 2016-12-27 | 8,400 | — | $0 | 58,400 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-03-15 | 2016-03-16 | 155,000 | — | $0 | 155,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-03-15 | 2016-03-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-03-15 | 2016-03-16 | 50,000 | — | $0 | 50,000 | SEC↗ |